Close
Nordic 9Nordic 9

Tolremo Therapeutics (private company)

Switzerland tolremo.com
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechHealth servicesManufacturing
Business model:B2B

Tolremo Therapeutics is a Swiss biotech company focused on non-genetic cancer drug resistance, developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 39M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Tolremo Therapeutics

Name Criteria
Germany CatalYm
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Peptone
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Austria Sarcura
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Xenothera
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Eyevensys
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top